omniture
logo
Search
Samsung Biologics Co. Ltd.
Media Room

Latest News

rss

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced to...

2020-07-21 20:20 16595
Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced a plan t...

2020-07-21 10:13 15867
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Th...

2020-07-15 13:46 1636
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expand...

2020-07-12 08:00 1523

Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

SONGDO, South Korea, June 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the launc...

2020-06-08 19:00 1638
Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) an...

2020-05-22 07:11 6275

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has at...

2020-05-20 07:11 1699
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia T...

2020-04-23 08:00 1258

Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced Q1...

2020-04-22 19:00 5969

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) ...

2020-04-10 11:39 2462

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it ...

2020-04-08 20:00 1136
Samsung Biologics named Champion in 2020 CMO Leadership Awards

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a str...

2020-04-06 08:00 1007

Samsung Biologics expands leadership for CDO business

SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has appointedEun ...

2020-03-30 21:00 1344
Samsung Biologics expands leadership for CDO business

Samsung Biologics Adds Greater Expertise and Diversity to Its Board

SONGDO, South Korea, March 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the app...

2020-03-20 20:00 2283
Samsung Biologics Adds Greater Expertise and Diversity to Its Board

Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate

SONGDO, South Korea, March 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a co...

2020-03-17 08:04 1329

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announc...

2020-03-03 03:00 1109

Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect

SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-...

2020-02-27 15:49 1367

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract M...

2020-02-04 13:50 951

Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO

INCHEON, South Korea, Nov. 14, 2019 /PRNewswire/ -- Samsung Biologics announced that it has obtaine...

2019-11-14 20:00 1275

Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830

INCHEON, South Korea, Nov. 4, 2019 /PRNewswire/ -- Samsung Biologics announced the signing of a lon...

2019-11-05 08:22 1035
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830
12345